316 related articles for article (PubMed ID: 28840596)
1. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
Haukka J; Niskanen L; Auvinen A
Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
4. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
5. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
[No Abstract] [Full Text] [Related]
6. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
8. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
[TBL] [Abstract][Full Text] [Related]
9. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
10. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
[TBL] [Abstract][Full Text] [Related]
11. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
12. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
13. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
[TBL] [Abstract][Full Text] [Related]
14. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients.
Lehman DM; Lorenzo C; Hernandez J; Wang CP
Diabetes Care; 2012 May; 35(5):1002-7. PubMed ID: 22456867
[TBL] [Abstract][Full Text] [Related]
15. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
16. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
17. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
18. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
[TBL] [Abstract][Full Text] [Related]
19. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study.
Vicentini M; Ballotari P; Giorgi Rossi P; Venturelli F; Sacchettini C; Greci M; Mangone L; Pezzarossi A; Manicardi V
Diabetes Res Clin Pract; 2018 Sep; 143():398-408. PubMed ID: 29807100
[TBL] [Abstract][Full Text] [Related]
20. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
